XLON
WIL
Market cap326mUSD
Jul 10, Last price
290.00GBP
1D
6.62%
1Q
20.83%
Jan 2017
8.61%
Name
Wilmington PLC
Chart & Performance
P/E
22.47
P/S
2.56
EPS
0.13
Div Yield, %
4.23%
Shrs. gr., 5y
0.53%
Rev. gr., 5y
-2.14%
Revenues
101m
+3.22%
Net income
12m
-71.95%
CFO
17m
-24.74%
Dividend
Oct 30, 20258.5 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Wilmington plc, a London, UK-based company established in 1995 (and known as Wilmington Group plc until its name change in February 2015), offers a comprehensive suite of data intelligence, professional training, and educational services to global professional markets. The company operates through two distinct segments: Information & Data and Training & Education. The Information & Data division supplies essential risk and compliance data to diverse sectors like insurance, pensions, and healthcare. This segment also delivers critical insights and events for professional practice management, provides witness training and conference support, and offers cloud-based solutions, CRM, KAM, and consultancy to the pharmaceutical industry. Further offerings include business intelligence, data analysis, workflow tools, specialized reference materials, legacy information, Spanish language publications, trust and shared services, and support for professional associations. The Training & Education division delivers compliance-focused learning and technical expertise, encompassing formal qualifications, continuous professional development, and mandatory training via both instructor-led and self-guided methods. It serves industries such as financial services, accountancy, and healthcare, with a curriculum that includes anti-money laundering courses, online healthcare education, advanced legal training, marketing assistance for accountants, and intelligence and investigative skills development. This division also orchestrates specialist conferences and networking events in the healthcare and finance sectors.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||